The U.S. healthcare sector experienced a turbulent trading session on April 17, 2025, as UnitedHealth’s UNH earnings disappointment sent ripples through insurer stocks. However, strong gains in ...

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

Por TOM MURPHYUn sorprendente aumento en los costos de Medicare Advantage ayudó a que UnitedHealth experimentara una infrecuente caída profunda el jueves, después de que el gigante ...

For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

UnitedHealth Group is seen as the pacesetter for Medicare Advantage, but some analysts view its poor first quarter as an ...

UnitedHealth has traditionally been a company investors saw as reliable, having not missed earnings estimates since the 2008 global financial crisis.

The selloff in UnitedHealth's stock was weighing on shares of its peers, as Humana Inc.'s (HUM) dropped 7.4%, CVS Health Corp.'s (CVS) were down 1.8%, Elevance Health Inc.'s slid 2.4% and Centene Corp ...

A surprising Medicare Advantage cost spike helped push UnitedHealth into a rare deep dive Thursday, after the health care ...

High Medicare Advantage spending continues to dog major carriers such as Elevance Health and UnitedHealth Group.

Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs.

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

Elevance Health (NYSE:ELV) on Thursday issued its preliminary financial results for Q1 2025, projecting $9.61 of GAAP net ...